INTRODUCTION
============

The incidence of breast cancer ranks second among all cancers and first among female cancer, with large differences in occurrence by country and race \[[@B1]\]. In addition to genetic factors, such as family history, nongenetic factors, such as menstruation status, fertility, and hormonal intake are known to increase breast cancer risk \[[@B2][@B3]\]. However, further studies on the recent rapid increase in the incidence of breast cancer in areas with previously low incidence, such as Asia are needed \[[@B4][@B5][@B6][@B7]\].

Meanwhile, the prevalence of diabetes is increasing worldwide, especially in Asia \[[@B8][@B9][@B10]\]. Therefore, there is a need to test hypotheses such as the relationship between diabetes and the risk of breast cancer. [Table 1](#T1){ref-type="table"} summarizes the results of the seven systematic reviews (SR) conducted to analyze this hypothesis \[[@B11][@B12][@B13][@B14][@B15][@B16][@B17]\]. In all SR except Anothaisintawee et al. \[[@B16]\], a history of diabetes mellitus increased the risk of breast cancer. However, the results of subgroup analyses according to menopausal history in four SR \[[@B12][@B13][@B14][@B15]\] showed that the statistical significance of the risk was maintained in post-menopausal women, while the risk level and statistical significance lowered in pre-menopausal women.

The risk for Asian women were inconsistent in the results of two SR with ethnic subgroup analysis \[[@B13][@B14]\]. This needed to be re-analyzed by study design because the result was a combination of prospective cohort studies and case-control studies. In addition, the literature search period was March 2010 in Liao et al. \[[@B14]\] so it is necessary to further select and re-analyze the results of cohort studies on East Asian women published since then. Thus, the author performed a meta-epidemiological study (MES) to investigate the association between diabetes and risk of breast cancer in East Asian women \[[@B18][@B19]\].

MATERIALS AND METHODS
=====================

The subjects of this MES are the articles selected from previous SRs evaluating the same hypothesis \[[@B18]\]. Seven SR presented in [Table 1](#T1){ref-type="table"} selected six Asian women\'s cohort papers \[[@B20][@B21][@B22][@B23][@B24][@B25]\]. As the latest publication year of these was 2014, it was necessary to include additional papers up until the time of writing, September 18, 2019 \[[@B25]\]. A list of articles citing seven SRs in [Table 1](#T1){ref-type="table"} and six Asian cohort papers selected by them was constructed using the 'cited by' option suggested by PubMed \[[@B26]\]. In the papers listed, the papers for inclusion in this MES were selected according to the following criteria: (1) The study participants were healthy women of East Asian descent; (2) the study was conducted by a prospective cohort design; (3) the results showed the effect size for risk of breast cancer according to diabetes mellitus status.

In the studies with same cohort participants, the paper having with the longest follow-up period was selected as representative of the cohort. The effect size of the selected papers was estimated from the adjusted relative risk (RR) and 95% confidence intervals (CI). Then, logarithm RR (logRR) and standard error of logRR of each paper was calculated.

The level of heterogeneity was evaluated with the I-squared value (%) and summary RR (sRR) and 95% CI were estimated by applying the random effect model if over 50% of I-squared value \[[@B27]\]. Egger\'s test was conducted for publication bias \[[@B28]\] and statistical significance level was set at 0.05.

RESULTS
=======

There was a total of 734 articles cited as of September 18, 2019 by the citation discovery tools (CDT) \[[@B26]\]. Four new cohort studies could be added after applying the selection criteria \[[@B29][@B30][@B31][@B32]\]. Two articles among the six cohort studies selected in 7 SRs of [Table 1](#T1){ref-type="table"} were deleted because Goodman et al. \[[@B20]\] used a cohort of atomic bomb survivors and Bi et al. \[[@B25]\] reported results as a prevalence ratio.

Thus, critical appraisals for extracting information were performed on a total of eight articles from the four cohorts selected by the previous SRs and the four cohorts added by the CDT \[[@B21][@B22][@B23][@B24][@B29][@B30][@B31][@B32]\] The distribution of nationality was 3 from Japan \[[@B22][@B23][@B31]\], 3 from Taiwan \[[@B24][@B29][@B30]\], 1 from Korea and 1 from China. Sasazuki et al. \[[@B31]\] conducted a pooled analysis from 8 major cohorts in Japan so that two cohorts in Japan \[[@B22][@B23]\] were excluded for meta-analysis. All three Taiwan cohort studies conducted from National Health Insurance Databases, therefore Lee et al. \[[@B29]\] with the longest follow-up period was selected among them. Thus, four cohort studies \[[@B21][@B29][@B31][@B32]\] were finally selected as the prospective cohort studies that reported the risk of breast cancer with diabetes in East Asian women. The total number of participants was 1,448,254, and only Pan et al. \[[@B32]\] included the results adjusted for menopausal history ([Table 2](#T2){ref-type="table"}).

The studies in Korea and China among 4 cohorts showed a statistically significant result \[[@B21][@B32]\]. However, the meta-analysis applying the random effect model showed no statistical significance (sRR = 1.20, 95% CI = 0.98--1.46, I-squared = 63.1%) ([Fig. 1](#F1){ref-type="fig"}). The *P* value of Egger\'s test was 0.50.

DISCUSSION
==========

To summarize, there is no association between diabetes and risk of breast cancer in East Asian women. However, it could not be concluded that this was caused by racial difference between Westerners and Asians. The reasons were as follows: first, results of Pan et al. \[[@B32]\] showed the risk of breast cancer with diabetes in post-menopausal women (RR = 1.26, 95% CI = 1.02--1.56), but there was no statistical significance in pre-menopausal women (RR = 1.05, 95% CI = 0.65--1.69); secondly, it should be considered that the age of onset of breast cancer in East Asian women including Korean is younger than for Western women \[[@B4]\]. In other words, the main reason for a lack of statistically significant association between diabetes and breast cancer risk in East Asian women compared to Western women was the fact that breast cancer patients in East Asians had relatively younger age and therefore studies on this population included more pre-menopausal breast cancer patients.

Wolf et al. \[[@B11]\] pointed out that a detection bias could be introduced because diabetic patients could have higher possibility of screening for breast cancer. However, subsequent studies have reported similar or fewer breast cancer screenings to those with diabetes than those without diabetes \[[@B33]\]. Additionally, Bowker et al. \[[@B34]\] argued a possibility of detection bias because postmenopausal women were at increased risk of breast cancer within the first three months of diagnosing diabetes (RR = 1.31, 95% CI = 0.92--1.86). However, there is insufficient evidence to interpret the difference in risk according to menopause as a detection error since there is no statistical significance.

For the different effects on menopause status on the relationship between diabetes and the risk of breast cancer, it was thought to be due to anatomical differences in breast cancer before and after menopause \[[@B35]\] or an estrogen effect \[[@B36]\]. Although it is still controversial \[[@B37]\], it is possible that obesity may increase the risk of breast cancer in post-menopausal women but not in pre-menopausal women \[[@B38][@B39]\], as diabetes and breast cancer both have obesity as a common risk factor \[[@B11][@B40]\]. However, Pan et al. \[[@B32]\] suggested that diabetes increased the risk of breast cancer even when the menopause and obesity levels were adjusted for (RR = 1.21, 95% CI = 1.01--1.47).

Therefore, research from various perspectives is needed to provide a clearer interpretation. In particular, for a more valid interpretation of the risk of breast cancer with diabetes according to menopausal status, it is necessary to consider menopausal status and hormone intakes to alleviate menopausal symptoms, as well as the blood sugar level at the time of first diagnosis, the duration of diabetes after the first diagnosis, the history of diabetes control, and the complications of diabetes \[[@B40]\]. In addition, in view of the relatively young age of breast cancer in Asian women, it is necessary to conduct a nested case-control study to investigate the risk of breast cancer in diabetic disease according to the menopause history at the time of breast cancer.
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###### Summary of subgroup analyses in previous systematic reviews
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  Study (year) \[reference number\]   Search to   Variable         Selected articles   Summary RR   95% CI
  ----------------------------------- ----------- ---------------- ------------------- ------------ ------------
  Wolf (2005) \[[@B11]\]              Jun. 2004   Cohort           6                   1.25         1.19--1.31
  Xue (2007) \[[@B12]\]               Dec. 2006   Cohort           11                  1.16         1.12--1.20
                                                  Pre-menopause    3                   0.92         0.78--1.10
                                                  Post-menopause   6                   1.19         1.15--1.22
  Larsson (2007) \[[@B13]\]           Feb. 2007   Cohort           15                  1.20         1.12--1.28
                                                  Pre-menopause    3                   0.91         0.62--1.34
                                                  Post-menopause   8                   1.16         1.08--1.23
                                                  America          9                   1.12         1.06--1.18
                                                  Europe           7                   1.19         1.08--1.31
                                                  Asia             4                   1.45         1.07--1.97
  Liao (2011) \[[@B14]\]              Mar. 2010   Cohort           7                   1.22         1.10--1.34
                                                  Pre-menopause    3                   1.15         0.91--1.64
                                                  Post-menopause   5                   1.25         1.20--1.30
                                                  America          6                   1.16         1.12--1.20
                                                  Europe           3                   1.88         1.56--2.25
                                                  Asia             3                   1.01         0.84--1.21
  Boyle (2012) \[[@B15]\]             Oct. 2011   Cohort           22                  1.23         1.12--1.35
                                                  Pre-menopause    5                   0.86         0.66--1.12
                                                  Post-menopause   10                  1.15         1.07--1.24
  Anothaisintawee (2013) \[[@B16]\]   Jan. 2011   Cohort           9                   0.97         0.80--1.17
  Bernard (2016) \[[@B17]\]           2015        Cohort           8                   1.32         1.06--1.65

RR: relative risk, CI: confidence interval.

###### Four selected cohort studies in Asian women
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  Characteristic             Study (year) \[reference number\]                                                                                                                                                                                                                                                                
  -------------------------- -------------------------------------------------- -------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------
  Nation                     Korea                                              Taiwan                                             Japan                                                                                                                                                                                      China
  Source of cohorts          KCPS                                               NHI                                                8 cohorts                                                                                                                                                                                  CKBS
  Participants (women)       468,615                                            497,037                                            182,542                                                                                                                                                                                    300,060
  Age of entry (y)           49.6 (mean)                                        \<30 (mode)                                        40 (minimum)                                                                                                                                                                               51.5 (mean)
  Follow-up periods (year)   1993--2002                                         1998--2009                                         1984--2009                                                                                                                                                                                 2009--2013
  HR (95% CI)                1.51 (1.26--1.80)                                  1.01 (0.74--1.37)                                  0.98 (0.69--1.38)                                                                                                                                                                          1.21 (1.01--1.47)
  Adjusted variables         Age, age squared, amount of smoking, alcohol use   Age, history of hypertension, dyslipidemia, gout   Age, area, history of cerebrovascular disease, coronary heart disease, cigarette smoking, alcohol consumption, body mass index, physical exercise, green leafy vegetables, coffee intake   Age, study area, education, parental history of cancer, body mass index, cigarette smoking, alcohol drinking, physical activity, menopausal status

KCPS: Korean Cancer Prevention Study, NHI: National Health Insurance, CKBS: China Kadoorie Biobank Study, HR: hazard ratio, CI: confidence interval.
